AbbVie
ABBV
ABBV
1,421 hedge funds and large institutions have $56.7B invested in AbbVie in 2014 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 493 increasing their positions, 655 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
3% less capital invested
Capital invested by funds: $58.2B → $56.7B (-$1.49B)
14% less funds holding in top 10
Funds holding in top 10: 59 → 51 (-8)
25% less repeat investments, than reductions
Existing positions increased: 493 | Existing positions reduced: 655
Holders
1,421
Holding in Top 10
51
Calls
$323M
Puts
$156M
Top Buyers
| 1 | +$180M | |
| 2 | +$120M | |
| 3 | +$116M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$107M |
| 5 |
HCM
Highline Capital Management
New York
|
+$105M |
Top Sellers
| 1 | -$253M | |
| 2 | -$213M | |
| 3 | -$202M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$200M |
| 5 |
Lazard Asset Management
New York
|
-$153M |